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ABSTRACT
Over the course of two years (2021-2022), two experiments were conducted during the
nonbreeding seasons to evaluate the in vitro developmental potential of oocytes derived from
seasonally anovulatory mares treated with ECP-sulpiride. The objective of experiments 1 and 2
were to compare pooled recovery and maturation rates of oocytes from mares treated with
estradiol cypionate (ECP) and sulpiride with oocytes collected from naturally transitional mares
(controls). Cleavage rates of oocytes subjected to intracytoplasmic sperm injection (ICSI) were
compared only in experiment 2. In experiments 1 and 2, a total of 36 light horse and pony-cross
anovulatory mares were used. Treatment was administered intramuscularly and consisted of 50
mg ECP followed by 3 g sulpiride (n = 18) in sucrose acetate isobutyrate (SAIB), while controls
received vehicle only (n = 18). Jugular blood samples were collected prior to treatment and
continued daily for 12 days in order to characterize plasma LH and prolactin concentrations. All
mares were subjected to ovum pick up (OPU) when the first 30 mm follicle of the season was
detected. All follicles ≥ 8 mm were targeted for OPU and aspirates from three follicle diameter
categories (8-19 mm, 20-29 mm, and > 30 mm) were pooled within treatment groups. In
experiments 1 and 2, 7/7 and 10/11 ECP-sulpiride treated mares responded within 15 days of
treatment. Mean day to first 30 mm follicle of ECP-sulpiride treated mares was advanced in
experiments 1 (P = 0.005) and 2 (P = 0.0007) by 23 and 19 days, respectively. In both
experiments, plasma prolactin and LH increased (P ≤ 0.0001) in all mares treated with ECPsulpiride for at least 7-10 days after treatment. The recovery and maturation rates of oocytes
from ECP-sulpiride and vehicle only treated mares did not differ (41.6 vs 45%; P = 0.77 and
55.6 vs 65.4%; P = 0.47, respectively) and there was no significant effect on follicle diameter.
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Cleavage rates of oocytes subjected to ICSI did not differ between ECP-sulpiride and vehicle
only treated mares (71.4 vs 61.3%; P = 0.99, respectively).
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CHAPTER 1. INTRODUCTION
Many breed associations consider January 1 as the official birth date for foals born in the
same season. There is considerable competitive and economic incentive to induce early cyclicity
in mares, so they foal as close to the January 1 birth date as possible. In the Northern
hemisphere, the breeding season begins in late spring and ends in early fall, with a period of
anovulation during the winter. The seasonal nature of the mare’s reproductive cycle has led to
the development of techniques to manipulate cyclicity to satisfy the universal birthday standard.
The most common method is the use of artificial lighting, considering the mare’s reproductive
cycle is dictated by photoperiod. However, this process has proven to be costly and does not
effectively bypass the erratic ovarian activity associated with the spring transition. Another
promising approach is through stimulating the release of the hypophyseal hormone prolactin
using dopamine antagonists, such as sulpiride. Pretreatment with ECP one day prior to a single
injection of sulpiride in SAIB vehicle is sufficient to stimulate most seasonally anovulatory
mares to cycle as early as February, significantly advancing the first ovulation of the year, given
that most mares normally begin to cycle in early April. Assisted reproductive technologies
(ART) such as ovum pick up and intracytoplasmic sperm injection, can be used to collect
oocytes from mares to produce embryos in vitro regardless of season. While these technologies
were initially used to address fertility problems of sub-fertile mares or stallions with poor
reproductive performance in vivo, it is becoming commonplace for owners to enroll horses of
normal fertility in OPU-ICSI programs.
While clinical OPU-ICSI programs in horses has gained popularity in recent years,
optimization is still needed. Efficiency of OPU-ICSI programs is greatly influenced by an
oocyte’s developmental competence, which is the germ cell’s ability to mature, cleave following
1

fertilization, develop to the blastocyst stage, and generate a viable offspring (Sirard et al., 2006).
Current success rates of commercial equine ICSI procedures are relatively low, yielding an
average of 1.2 blastocysts per OPU session (Hinrichs et al., 2014).
Inducing early cyclicity in seasonally anovulatory mares with ECP-sulpiride results in
follicular activity similar to that of an unstimulated, cycling mare. Ovulations from ECPsulpiride stimulated follicles are fertile and ECP-sulpiride treated mares are capable of sustaining
morphologically normal pregnancies with cardiac activity (Oberhaus et al., 2017). In vitro
developmental competence of oocytes obtained from stimulated follicles of anovulatory mares
has yet to be determined. If oocytes derived from seasonally anovulatory mares treated with
ECP-sulpiride have equal developmental potential to oocytes from naturally occurring follicles
in the spring, then they could be utilized for the in vitro production of embryos through OPU and
ICSI.
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CHAPTER 2. REVIEW OF LITERATURE
2.1. The Hypothalamic-Hypophyseal-Ovarian Axis
Regulation of mammalian reproduction begins at the level of the brain in the
hypothalamus. The hypothalamus is a neuroendocrine organ that sits just above the
adenohypophysis in the brain, connected by the hypophyseal stalk. Communication between the
hypothalamus and hypophysis is achieved through a system of blood vessels located between the
two organs referred to as the hypothalamic-hypophyseal portal system. Gonadotropin-releasing
hormone (GnRH), a 10 amino acid neuropeptide, is released in a pulsatile fashion into portal
circulation, eventually binding to GnRH receptors on gonadotropes of the adenohypophysis to
signal the synthesis and release of follicle stimulating hormone (FSH) and luteinizing hormone
(LH). Follicle stimulating hormone and LH are glycoproteins that exert their actions on various
cell types in the ovary. Follicle stimulating hormone promotes ovarian follicular development
and estradiol synthesis while increasing concentrations of LH stimulate ovulation, followed by
the formation of the corpus luteum (CL) and subsequent progesterone secretion.
Interactions of gonadotropins with theca and granulosa cells promotes steroid synthesis
and secretion. Testosterone, estradiol, and progesterone are the main sex steroids produced by the
ovary that influence reproductive tract development and sexual behavior. Androgen production
in theca interna cells is mediated by LH and is aromatized into estradiol in neighboring granulosa
cells through the action of FSH. Steroids produced by the ovary are required for proper
stimulation and regulation of the hypothalamic-hypophyseal axis and its regulation of the estrous
cycle and reproductive behavior.
Regulation of GnRH and subsequent gonadotropin secretion in the mare is dictated by
season and phase of the estrous cycle. Among other environmental cues such as day length and
3

temperature, it has been postulated that melatonin plays a role in alteration of GnRH production
in respect to the changing seasons (Aurich, 2011). Secretion patterns of gonadotropins in a
cycling mare are differentially regulated according to GnRH pulse frequency. Higher GnRH
pulse frequency favors LH secretion while lower pulse frequency favors FSH secretion, with
frequency varying with stage of cycle. Steroids such as estradiol and progesterone are also
involved in regulation of GnRH secretion through positive and negative feedback mechanisms
(Clarke and Pompolo, 2005). Negative and positive feedback on GnRH by progesterone and
estradiol, respectively, fluctuates with respect to the phases of the mare’s estrous cycle.
Upstream negative feedback by progesterone on GnRH also reduces LH secretion. Estradiol has
a stimulatory effect on LH while progesterone is inhibitory. Together, hypothalamic,
adenohypophyseal, and ovarian hormones create an interconnected axis where action upon or
regulation of one part greatly affects the other. The mechanisms elucidated herein provide the
appropriate endocrine environments needed for proper modulation of the mare’s estrous cycle.

2.2. Estrous Cycle of the Mare
The estrous cycle of the mare occurs over an average period of 21 days and consists of
two main phases, the follicular phase (estrus) and the luteal phase (diestrus; Raz and AharonsonRaz, 2012).
2.2.1. Follicular Phase
The estrous cycle is defined as the period of time between two consecutive ovulations,
accompanied with behavioral estrus and sexual receptivity to a stallion (Satué and Carlos
Gardon, 2021). GnRH from the hypothalamus stimulates release of FSH, the adenohypophyseal
gonadotropin responsible for follicular recruitment and development. The ovaries of a cycling
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mare are highly active during the breeding season and are characterized by the presence of
multiple smaller antral follicles and a single, large dominant follicle that is ovulated. The process
of ovarian follicular dynamics occurs continuously throughout the estrous cycle. In the female,
antral follicles emerge from a reservoir of small antral follicles located within the ovary that are
recruited into follicular waves primarily by FSH (Monniaux et al., 2014). Post-emergence, antral
follicles enter the common growth phase, increasing in size at the same rate, about 3 mm per day,
for 6-7 days. At the end of the common growth phase, deviation occurs, where the follicle
selected for dominance continues to grow while the remaining cohort of antral follicles regress.
Follicle deviation involves inhibin, a glycoprotein hormone produced by granulosa cells in the
ovaries. Inhibin decreases synthesis and secretion of FSH from the gonadotropes, forcing
subordinate follicles to cease further development. Concomitantly, increasing LH concentrations
and LH receptor content within the largest follicle contribute to the acquisition of dominance and
post-deviation follicle growth (Gastal et al., 2000). The dominant follicle continues to grow until
reaching a preovulatory size of 35-40 mm in diameter (Satué and Gardon, 2021). Throughout
this process, granulosa cells of the dominant follicle are producing estradiol. Follicle-derived
estradiol concentrations peak during estrus, about 2 days before ovulation. Through positive
feedback on GnRH, increasing estradiol concentrations stimulate a preovulatory surge of LH,
resulting in ovulation of the dominant follicle.
2.2.2. Luteal Phase
The luteal phase of the estrous cycle immediately follows ovulation and is characterized
by minimal concentrations of estradiol, increasing concentrations of progesterone, and the
presence of a CL (Satué and Gardon, 2021). Formation of the CL involves remodeling of
granulosa and theca cells from the ruptured follicle into luteal tissue. Luteal cells are the primary
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source of progesterone during diestrus, reaching its peak at 8 days post-ovulation (Aurich, 2011).
In the pregnant mare, the CL remains for the duration of gestation, providing the reproductive
tract with a progesterone-dominant environment to allow for sustainment of pregnancy. In the
non-pregnant mare, the CL will undergo luteolysis, which is the degradation of the corpus
luteum. Similar to other species, luteolysis in the mare is initiated by an oxytocin (OT) stimulus,
most likely originating from the neurohypophysis and endometrium (McCracken et al., 1999;
Aurich, 2011). Oxytocin stimulates the release of prostaglandin F2α (PGF2α) from the
endometrium, initiating the degradation of the CL. Diestrus comes to an end upon the completion
of luteolysis and is coupled with a decline in progesterone. Reduction in progesterone and rising
estradiol and FSH concentrations allow a new follicular wave to develop, and the cycle is
repeated every 21 days throughout the breeding season.

2.3. Seasonality of Reproduction
The mare experiences seasonal reproductive activity with recurring ovulatory periods
during the spring and summer months and an anovulatory period during the winter. The seasonal
nature of the mare is an evolutionary tactic to ensure foals are born when conditions are most
favorable. Phases of the annual reproductive rhythm include the breeding season, autumnal
transition, winter anestrus, and spring transition. Hypothalamic GnRH secretion previously
absent for the duration of anestrus is restored during the spring transition and is paralleled with
the increase in photoperiod and environmental temperatures in early spring. The first ovulation
of the year marks the end of the spring transition and the beginning of the breeding season. The
breeding season in the northern hemisphere begins in April or May and continues until the
autumnal transition in early fall. The mare will experience recurring periods of estrus
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accompanied by an average of 7 ovulations during the breeding season, with each estrual period
lasting a range of 4-7 days out of the 21-day cycle (Ginther, 1974; Raz and Aharonson-Raz,
2012). Nearing the autumnal transition, days begin to shorten and gonadotropin secretion from
the adenohypophysis is reduced, resulting in decreased ovarian activity (Nagy et al., 2000). The
transition into and out of the breeding season is a gradual process and most mares do not
transition in synchrony.
During the winter, most mares are anovulatory, ceasing opportunities for breeding until
spring. Ovarian activity is significantly reduced or absent during winter anestrus. Ovaries often
become small and inactive due to suppression of GnRH, preventing the prolonged LH surge
needed to achieve regular ovulations. Follicular waves may occur during winter anestrus due to
uninterrupted FSH concentrations, but ovulation typically does not follow. Steroidal activity is
greatly reduced during winter anestrus. Circulating estradiol is present at basal concentrations
while progesterone concentrations are less than 1 ng/mL.
Industry desire for mares to foal as early in the year as possible motivates equine breeders
to ensure mares conceive during the limited breeding season. Therefore, understanding of the
endocrine mechanisms influencing equine seasonality is imperative for efficient breeding
management and manipulation of the estrous cycle.
2.4. Prolactin
Prolactin is a short chain polypeptide hormone synthesized in and secreted by lactotropes
in the adenohypophysis (Freeman et al., 2000). Prolactin is primarily recognized for its role in
mammary growth, development, and lactogenesis in mammals (Freeman et al., 2000; Hadley and
Levine, 2007). However, prolactin has a diverse range of functions in reproduction in a multitude
of different species. In rats, prolactin is a luteotropic factor, aiding in CL development and
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progesterone production (Rothchild, 1981). Luteolysis of the murine CL is also induced by
prolactin secretion (Rothchild, 1981). In livestock such as horses and goats, increased prolactin
concentrations are a stimulant of seasonal hair shedding (Thompson et al., 1997; Donadeu and
Thompson, 2002; Celi et al., 2003). Prolactin receptor expression is also present in testicular
tissues and spermatogenic cells of male rodents, signifying a role in the regulation of
spermatogenesis (Hondo et al., 1995; Ishida et al., 2010). Hyperprolactinemia is known to cause
irregular ovarian activity in women, frequently leading to menstrual disturbance and infertility
(Crosignani, 2012). The myriad of physiological effects of prolactin on the mammalian
reproductive system is efficiently regulated by neuroendocrine mechanisms.
Regulation of prolactin secretion occurs through a short loop feedback system where
prolactin itself stimulates its own inhibitory factor, dopamine. Dopamine, a catecholamine
neurotransmitter, is released from dopaminergic neurons located in the arcuate nucleus of the
hypothalamus (Grattan, 2015). Three sub-populations of dopamine neurons serve as regulators of
prolactin secretion: the tuberoinfundibular (TIDA), tuberohypophyseal (THDA), and
periventricular hypophyseal (PHDA) neurons. Elevated levels of endogenous prolactin stimulate
dopamine synthesis by interaction with these dopamine neurons. The TIDA neurons of the
arcuate nucleus are responsible for the release of dopamine in a pulsatile pattern directly into the
hypothamalo-hypophyseal portal system, making TIDA neurons the major regulator of
hypophyseal prolactin secretion (Freeman et al., 2000; Grattan, 2015). Dopamine sourced from
TIDA neurons binds to D2 and D4 dopamine receptors on lactotrophs in the adenohypophysis,
inhibiting calcium from entering the cell (Grattan, 2015). Interruption of this calcium influx
results in membrane hyperpolarization, which reduces prolactin secretion from lactotropic cells
(Grattan, 2015). Dopamine also suppresses adenylate cyclase activity within the lactotrope cell,
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reducing prolactin gene expression (Grattan, 2015). Estradiol has a role in the regulation of
prolactin secretion (Grattan, 2015). Ovarian estradiol interacts with TIDA neurons to decrease
dopamine release, enabling prolactin secretion. Estradiol can also interact with lactotropes to
increase prolactin gene expression and therefore increases prolactin levels (Grattan, 2015).
Inhibitory activity of dopamine neurons on prolactin is dependent on prolactin concentrations in
circulation.
Circulating prolactin binds to the prolactin receptor (PRLr) located within the membrane
of target cells. King et al. (2010) validated that equine prolactin and its receptor were present
within ovarian tissues. Using immunohistochemistry, Oberhaus et al. (2015) further elucidated
the presence of PRLr within follicular tissue and corpora lutea of summer cycling, winter
cycling, and anestrous mares. PRLr staining intensity increased with follicle diameter and was
highest in antral follicles of summer cycling mares. Positive PRLr staining was also observed in
luteal cells and oocytes plus surrounding granulosa cells. Peaks in prolactin concentrations right
before or immediately after luteolysis have been reported in the mare (Irvine et al., 2000).
Presence of prolactin in follicular fluid in addition to a periovulatory prolactin surge in the mare
has also been reported (King et al., 2008). The authors described a positive association between
prolactin and follicle diameter, suggesting that the amount of follicular prolactin fluctuates in
relation to the growth of the follicle (King et al., 2008). Associations of prolactin concentrations
with stage of cycle and follicle diameter, in addition to the presence of prolactin and its receptor
within the equine ovary, suggests that prolactin plays a possible role in follicle growth,
development, and luteal function (Oberhaus et al., 2018).
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2.5. Estrous Cycle Manipulation
Historically, the most common method of cycle manipulation is the use of artificial
lighting (Burkhardt, 1947; Kooistra and Ginther, 1975). However, this process has been proven
to be costly and often does not entirely bypass the erratic ovarian activity associated with the
spring transition. Obstacles associated with artificial lighting has led to the development of
pharmacological methods to manipulate the mare’s estrous cycle. Administration of GnRH and
GnRH agonists have been used to stimulate gonadotropins, mainly LH, to induce ovulations in
seasonally anovulatory mares (Johnson, 1987; Hyland and Jeffcott, 1988; Fitzgerald et al., 1993;
Williams et al., 2007). Still, responses to treatment with GnRH and its agonists have produced
variable success as the response to treatment is dependent on the depth of anestrus and ovarian
activity before treatment (Fitzgerald et al., 1993; Mumford et al., 1994; Nagy et al., 2000). Lapin
and Ginther (1977) found success in inducing single and multiple ovulations in seasonally
anovulatory pony mares using equine pituitary extract; however, these products are not
commercially available, making clinical application impractical (Nagy et al., 2000).
Researchers noticed a correlation between seasonal reproductive rhythm of the mare and
prolactin concentrations. Hypophysis and serum prolactin concentrations are highest in summer
cycling mares and lowest during winter anestrus and are directly associated with changes in
photoperiod and environmental temperature (Johnson, 1986; Thompson et al., 1986). This
discovery led to the administration of exogenous and stimulation of endogenous prolactin to
manipulate the estrous cycle. Thompson et al. (1997) administered recombinant porcine prolactin
(rpPRL) to seasonally anestrous mares which resulted in a hastened date to first ovulation of the
year. While an increase in prolactin response to rpPRL treatment was observed, use of crossspecies prolactin resulted in antibody production against the hormone (Thompson et al., 1997).
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Additionally, sources of equine prolactin are not readily available for use in research. Hindrances
associated with the use of exogenous prolactin has led to the development of treatment protocols
to stimulate prolactin using dopamine antagonists.
2.5.1. Estradiol-Dopamine Antagonists
Dopamine antagonists such as domperidone, perphenazine, and metoclopramide have
been administered to increase prolactin concentrations in mares (Becker and Johnson, 1990;
Bennett-Wimbush et al., 1998; Brendemuehl and Cross, 2000; Kelley et al., 2006). It was also
reported that increasing endogenous prolactin concentrations by administration of a dopamine
antagonist (fluphenazine) can induce follicular growth and activity in anestrous mares (Nequin et
al., 1993). Utilization of the dopamine antagonist, sulpiride, to hasten the date of the first
ovulation of the year in mares has also shown promising results.
The first documented use of sulpiride in the horse was reported by Johnson and Becker
(1987). Sulpiride antagonizes dopamine secretion by competitively inhibiting dopamine from
binding to its D2 receptor on lactotropes. In this initial experiment, administration of sulpiride
resulted in an increase of serum prolactin concentrations in nonpregnant mares (Johnson and
Becker, 1987). In addition, sulpiride injections were able to advance the date to first ovulation in
anestrus and transitional mares (Besognet et al., 1997; Panzani et al., 2011).
Estradiol has been reported to increase hypophyseal prolactin content (Thompson et al.,
1991) as well as the prolactin response to sulpiride (Kelley et al., 2006; Clavier et al., 2012).
Kelley et al. (2006), administered every other day injections of estradiol benzoate (EB) in
vegetable oil for a total of 10 injections, followed by daily sulpiride injections 11 days later.
Pretreatment of seasonally anovulatory mares with EB enhanced the prolactin response to
sulpiride and subsequent LH concentrations, with treated mares ovulating an average of 45 days
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earlier than controls (Kelley et al., 2006). Still, such treatment needed to be simplified for
practical application. Thompson et al. (2008) compared the efficacy of two different singleinjection estradiol deliveries to every other day EB injections in geldings. In comparison to the
results seen with every other day EB administration, a single injection of 100 mg ECP resulted in
the most similar response to treatment (Thompson et al., 2008).
Success of estradiol-sulpiride treatment depends on the protocol used. The duration of
endogenous prolactin stimulation by sulpiride administered subcutaneously (Thompson and
DePew, 1997) or intramuscularly (Besognet et al., 1997) in oil is brief. It has been suggested that
the duration of prolactin stimulation is most likely contributing to an ovarian response of treated
mares (Oberhaus et al., 2018). The estradiol-sulpiride treatment protocol could be further
simplified by combining the dopamine antagonist with a long-acting vehicle that promotes
sustained elevated prolactin concentrations with a single injection. Sucrose acetate isobutyrate
(SAIB) is a hydrophobic polymer that is used to sustain the release of the GnRH analogue,
deslorelin, in the commercial product SucroMateTM Equine (Ferris et al., 2012; Thorn
Bioscience, Louisville, KY). In a study by Oberhaus, et al. (2022), the efficacy of SAIB as a
vehicle for both EB and sulpiride was assessed; prolactin and LH were stimulated for 10 and 14
days, respectively, supporting the use of SAIB as a vehicle.
Ovulations from ECP-sulpiride stimulated follicles are indeed fertile as demonstrated by
Oberhaus et al. (2017). In that study, 8 of the 9 responding mares treated with ECP-sulpiride
were artificially inseminated and induced to ovulate and 6 mares (75%) conceived and carried
morphologically normal pregnancies with cardiac activity up to 22 days. In a follow up study, it
was reported that ovulatory-sized follicles from seasonally anovulatory mares stimulated with
ECP-sulpiride appeared to have follicular fluid steroid hormone production and LH receptor
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expression equivalent to naturally occurring follicles in the spring (Oberhaus et al., 2018).
Concentrations of estradiol and progesterone, along with IGF-I, in the follicular fluid were
similar between groups. An interesting result to note is that prolactin concentrations in follicular
fluid were increased in ECP-sulpiride treated mares. The gene expression analysis of LH
receptors revealed that both stimulated and non-stimulated follicles shared similar LH receptor
expression levels (Oberhaus et al., 2018). Looman (2020) administered ECP-sulpiride to
anestrous, transitional, and progestin (altrenogest)-treated mares. Mean day to first ovulation of
all 3 ECP-sulpiride treated groups was advanced by 32 days when compared to mares that
received vehicle only. Ten embryos (4 frozen, 4 fresh, and 2 cloned) were transferred to mares in
each treatment group, and an overall pregnancy rate of 70% was achieved (Looman, 2020).

2.6. Oocyte Growth and Maturation
Oogenesis begins during early fetal life and ends in adulthood. During fetal development,
primordial germ cells (PGCs) migrate from the embryonic epiblast to the genital ridge and
eventually arrive at the gonad. Once in the developing ovary, PGCs enter mitosis, giving rise to
oogonia that undergo an incomplete cytokinesis, leading to the formation of germ cell nests
(Sánchez and Smitz, 2012). Oogonia then cease mitosis and enter meiosis where they are
considered primary oocytes (Sánchez and Smitz, 2012). The oocyte will progress through the
stages of prophase I of meiosis (leptotene, zygotene, pachytene) where a series of key events
occur, including the pairing of homologous chromosomes and genetic recombination (Pepling,
2013). At this time, the oocyte is enclosed in a single layer of pre-granulosa cells, creating the
primordial follicle, and remains arrested in the diplotene stage of prophase I (also known as the
germinal vesicle (GV) stage) until puberty (Pepling, 2013). At the start of the estrous cycle, a
limited number of primordial follicles enter the initial recruitment phase and develop into
13

primary and secondary (preantral) follicles. A small cohort of preantral follicles are selected to
develop to the antral stage, after which a single follicle gains dominance and advances to the
preovulatory stage. Throughout the progression of folliculogenesis, the diplotene arrested oocyte
grows and accumulates RNA and other cellular machinery needed for further growth and
maturation (Holt et al., 2013). After the preovulatory surge of LH, the oocyte will resume
meiosis and undergo germinal vesicle breakdown (GVBD). The oocyte progresses through the
stages of meiosis until arresting for a second time in metaphase II (MII), where the cell remains
until fertilization (Holt et al., 2013).
Oocytes gradually and sequentially acquire developmental competence during
folliculogenesis (Sánchez and Smitz, 2012). To participate in fertilization and embryo
development, an oocyte must have the ability to resume meiosis and mature to metaphase II
(Sirard et al., 2006). Meiotic competence, or the ability to resume meiosis, is acquired during the
transition from the preantral to antral follicle stages and involves incremental nuclear and
cytoplasmic changes accomplished using RNA stored during the growth phase (Pan and Li,
2019). Maturation promoting factor (MPF), a heterodimer of p34cdc2 (or CDK1) and cyclin B,
must be activated for the oocyte to resume germinal vesicle breakdown (GVBD) and enter
metaphase I (Kanatsu-Shinohara et al., 2000). Meiotic events following the LH surge involve
cell-cell communication between the oocyte and the surrounding somatic cells, chromatin
condensation during GVBD, chromosome segregation, and polar body extrusion (Coticchio et
al., 2014; Chavez et al., 2021). In addition, cytoplasmic and molecular maturation must be
completed for the oocyte to develop competently. Cytoplasmic maturation can be described as
the morphological changes that occur within the cytoplasm throughout oocyte growth and
concurrently with nuclear maturation to prepare the oocyte for fertilization and early embryonic
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development (Sirard et al., 2006). During early stages of follicle growth, the oocyte has high
transcriptional activity. As follicles grow to ovulatory size, RNA and protein synthesis is
gradually reduced until the oocyte reaches a dormant state, a process known as oocyte
capacitation (Hyttel et al., 1997; Gilchrist and Thompson, 2007). Nucleolus condensation and
ribosome depletion, due to reduced transcriptional and translational activities, are indicative of
cytoplasmic competence (Fair et al., 1995; Sirard, 2006). The redistribution of cellular
organelles, such as mitochondria and cortical granules, also occurs within the cytoplasm
(Ferreira et al., 2009). Molecular maturation involves the storage of undefined molecules within
the oocyte, most likely specific mRNAs and proteins that are necessary to promote the molecular
events needed to activate the embryonic genome (Sirard et al., 2006) Achievement of meiotic
competence along with cytoplasmic and molecular maturation is essential for oocyte growth and
crucial for the oocyte’s ability to develop into a viable embryo after fertilization (Sánchez and
Smitz, 2012).

2.7. In vitro Embryo Production
In vitro embryo production is an important technology used in the assisted reproduction
of domestic animals that aims to produce offspring outside of the maternal environment.
Production of embryos in this manner involves in vitro maturation (IVM) of recovered oocytes,
in vitro fertilization (IVF) or intracytoplasmic sperm injection of in vitro matured oocytes, and in
vitro culture (IVC) of presumptive zygotes up to the blastocyst stage (Paramio and Izquierdo,
2014). Success varies between species, with blastocyst rates ranging from 30-40% in bovine, 2050% in ovine, 40-50% in caprine, and 20% in equine (Camargo et al., 2006; Zhu et al., 2018;
Stout, 2020; Souza‐Fabjan et al., 2021). Efficiency of IVEP is dictated by an oocyte’s

15

developmental competence, which is described as the germ cell’s ability to complete nuclear and
cytoplasmic maturation, fertilize normally, develop to the blastocyst stage, and produce a healthy
offspring (Sirard et al., 2006; Gilchrist and Thompson, 2007).
Application of ART in the horse, such as OPU and ICSI, has made efficient IVEP
possible. Advances in ART in the horse have progressed relatively slowly when compared to
other livestock species, such as ruminants. Researchers cannot utilize abattoir-derived equine
ovaries to advance research as they have done in ruminants, but post-mortem collection of
oocytes for IVEP is an option to produce offspring from animals that die unexpectedly (Hinrichs
et al., 2012).
2.7.1. Ovum Pick Up
Another approach to oocyte recovery is OPU, which involves the ultrasound-guided
aspiration of follicles on the ovary using a 60-cm long, 12-gauge double lumen (Cook et al.,
1993). One option is to aspirate a single dominant, stimulated follicle to recover an in vivo
matured oocyte (Hinrichs, 2018). Administration of GnRH analogs or human chorionic
gonadotropin (hCG) 24-36 hours before aspiration stimulates the resumption of meiosis of the
oocyte within the dominant follicle, with the goal of collecting a mature oocyte just before
ovulation (Hinrichs, 2018). The MII oocyte may be transferred into the uterine tube of an
inseminated mare (Carnevale, 2004), subjected to ICSI and transferred surgically to the uterine
tube of a recipient (Choi et al., 2002), or cultured in vitro up to the blastocyst stage for
transcervical embryo transfer (Hinrichs et al., 2014). The recovery rates of pre-ovulatory follicles
are high, and these in vivo matured oocytes are developmentally competent (Hinrichs et al.,
1990). Growth of the dominant follicle needs to be monitored frequently and precise timing of
hCG/GnRH trigger needs to be coordinated with the ICSI laboratory (Hinrichs, 2018). Vigorous
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repeated flushing and scraping with the needle is needed to dislodge the tightly attached COC
from the follicle wall, which can be problematic due to the large size of the dominant follicle.
Because of the inconsistencies associated with superovulation in the mare (Alvarenga et al.,
2008), only one, or sometimes two, dominant follicles are available for aspiration in each estrus
during the breeding season (Hinrichs, 2018). Another approach to OPU is aspiration of all visible
subordinate follicles to recover immature oocytes for in vitro maturation. In this manner, OPU
can be performed year-round, on average once every 14 days, without stimulation or monitoring
of ovarian activity (Jacobson et al., 2010). Repeated OPU sessions have not been found to have
any detrimental effects on mare fertility (Mari et al., 2005; Vanderwall et al., 2006). From a
clinical standpoint, a population of multiple small to medium sized antral follicles (> 10 mm) on
the ovary is desired for OPU (Galli et al., 2014).
Earlier studies in the mare report recovery rates of immature oocytes ranging from 12.3%
to 84% varying with stage of cycle, follicle diameter, and technique used (Bracher et al., 1993;
Cook et al., 1993). Bracher et al. (1993) reported that aspirations from unstimulated, immature
follicles yielded higher oocyte recovery rates than hCG or PGF2α stimulated follicles. Stage of
estrous cycle has been reported to affect recovery rates, with higher oocyte recovery associated
with aspirations performed in cyclic, estrus mares when compared to aspirations performed
during diestrus (Cook et al., 1993). This study revealed an effect of follicle diameter on oocyte
recovery, where follicles < 15 mm produced higher (31%) recovery rates when compared to
follicles > 20 mm (8%) (Cook et al., 1993). Additionally, Purcell et al. (2007) compared
recovery rates of oocytes between transitional, cycling, and pregnant mares, based on small (1020 mm) and large (> 20 mm) follicle diameter. While there was no difference in rates between
cycling and transitional mares, the authors found that recovery from small follicles (21.6%) was
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greater than that of large follicles (11.7%; Purcell et al., 2007). It has been demonstrated that
cycling, transitional, and anestrous mares are suitable oocyte donors for OPU (Colleoni et al.,
2007; Iacono et al., 2014). Follicles during the non-breeding season are smaller, but the number
of follicles available for OPU does not differ significantly from that of the breeding season, and
oocytes collected during both seasons are capable of normal maturation and fertilization
(Hinrichs and Schmidt, 2000; Mak et al., 2018).
When targeting immature follicles, one may recover an average of 2 to 10 oocytes per
mare if adequate flushing of the follicle is achieved (Goudet et al., 1997; Galli et al., 2007;
Jacobson et al., 2010). ICSI programs are more efficient when all immature follicles are
aspirated rather than a single pre-ovulatory follicle (Hinrichs, 2018). This can be observed in a
study by Jacobson et al. (2010), which reported that aspiration of immature follicles yielded
more blastocysts per OPU session. Follicles ≤ 10 mm are more abundant on the ovary than larger
ones, so the increased blastocyst yield in this study is likely due to a higher number of oocytes
being available for manipulation, not their inherent developmental capacity. Developmental
potential of recovered equine oocytes is influenced by the size and maturity of the follicle it was
derived from and has been reported to increase with increasing follicle size (Hinrichs and
Schmidt, 2000). This can be observed in other species including the bovine (Lonergan et al.,
1994), porcine (Marchal et al., 2002), buffalo (Raghu et al., 2002), and human (Rosen et al.,
2008). Nevertheless, immature equine oocytes from smaller follicles can acquire meiotic
competence and reach MII when matured in vitro (Hinrichs, 1998).
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2.7.2. In Vitro Maturation
In vitro maturation may be achieved by placing immature oocytes into a controlled
culture environment to facilitate the completion of nuclear and cytoplasmic maturation. Upon
retrieval, oocytes may be placed directly into IVM or held overnight at room temperature.
Holding immature equine oocytes to delay maturation allows for overnight shipment of oocytes
to the ICSI laboratory (Galli et al., 2016). This practice also ensures that ICSI and other
manipulations can be performed at more convenient working hours (Hinrichs, 2020).
The earliest successful report of in vitro matured equine oocytes was that of Fulka and
Okolski (1981), followed by Zhang et al. (1989), whose work resulted in the first production of
equine embryos derived from IVM oocytes. Matured oocytes were transferred to the uterine
tubes of inseminated mares, recovered as day 7 blastocysts by uterine flushing, and transferred
into a recipient mare, resulting in one pregnancy (Zhang et al., 1989). Squires et al. (1996)
reported the first successful establishment of pregnancy accomplished using in vitro matured
oocytes subjected to ICSI using oocytes collected from abattoir derived ovaries. Choi et al.
(2004) also demonstrated that IVM oocytes subjected to ICSI were capable of blastocyst
formation in vivo. Furthermore, Hinrichs et al. (2005) reported the birth of two live foals derived
from IVM equine oocytes that underwent ICSI and cultured to the blastocyst stage in vitro.
These studies provide evidence that in vitro matured equine oocytes are capable of normal
maturation and embryonic development.
Equine cumulus oocyte complexes (COC) available for in vitro maturation are classified
as compact (Cp), expanded (Ex), or denuded (Dn). Most oocytes will have Cp or Ex cumuli, and
their meiotic competence may be correlated to their cumulus cell morphology. In other species,
such as the bovine, oocytes with multiple layers of healthy, compact cumuli are selected for IVM

19

and appear to have the highest meiotic competence; however, this is not necessarily the case for
the equine (Kakkassery et al., 2010). In a study by Hinrichs et al. (1997), Ex oocytes were most
likely to originate from atretic follicles (≤ 10 mm) while Cp oocytes were predominantly present
in growing follicles (> 20 mm). Cumulus expansion was associated with degree of atresia. In
several studies, Ex oocytes matured in vitro were found to reach MII at a faster rate and in higher
proportions when compared to Cp oocytes (Hinrichs et al., 1993; Hinrichs and Williams, 1997;
Hinrichs and Schmidt, 2000; Galli et al., 2007).
Commonly used media for equine IVM are tissue culture medium 199 (TCM 199) and
Dulbecco’s modified eagle medium/nutrient mixture F-12 (DMEM/F-12), which are
occasionally supplemented with fetal bovine serum (FBS), gonadotropins LH and FSH, and
antibiotics (Galli et al., 2007). Other components such as preovulatory follicular fluid and the
growth factors insulin-like growth factor I (IGF-I) and epidermal growth factor (EGF) have been
added to improve IVM conditions with variable success (Dell’Aquila et al., 1997; Aguilar et al.,
2001; Carneiro et al., 2001; Lorenzo et al., 2002). High quality commercial media are available,
and the formulation is generally similar, but the exact medium composition is kept confidential.
Equine oocytes are generally matured at 38.2ºC in a 5-6% CO2 environment in
atmospheric O2 (~21%) for 30 ± 2 hours (Squires, 1996). During oocyte maturation, cumulus
cells surrounding the oocyte will extrude extracellular matrix, causing separation of the cells
from one another, a process known as cumulus cell expansion (Nevoral et al., 2014). Expansion
of cumulus cells can be observed just before ovulation in vivo and during meiotic maturation in
vitro (Salustri et al., 1989). Metaphase II oocytes with an extruded first polar body present in the
perivitelline space are selected for fertilization by ICSI.
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2.7.3. Intracytoplasmic Sperm Injection
ICSI is a substantial technology applied in the assisted reproduction of domestic animals,
including the equine. Fertilization by ICSI involves the injection of a single spermatozoon into
the cytoplasm of a mature oocyte by means of micromanipulation under an inverted microscope
(Hinrichs, 2018). Since only one spermatozoon is required for fertilization, ICSI is useful in
cases where the stallion of choice has poor reproductive performance in vivo or when quantities
of semen are scarce and/or expensive (Carnevale et al., 2007). Mares unable to establish
pregnancy due to reproductive tract abnormalities, such as oviduct occlusion, chronic uterine
infection, and uterine fibrosis are also candidates for ICSI (Cuervo-Arango et al., 2019). In some
cases, clinical application of ICSI is also practiced with animals of normal fertility, since OPU
can be performed year-round requiring less time out of training and competition, no hormonal
stimulation, and a minimal amount of sperm.
The application of ICSI in the equine has improved the production of embryos in vitro,
unlike conventional in vitro fertilization in the horse. Two foals have been born as a result of
conventional IVF; however, in both instances, in vivo matured oocytes were used (Palmer et al.,
1991; Bezard, 1992). In other studies, fertilization of in vitro matured oocytes by conventional
IVF has resulted in the production of blastocysts, but a successful pregnancy was never
established (Meintjes et al., 1995; Hinrichs et al., 2002). Failure of IVF in the horse may be
attributed to inadequate sperm capacitation in vitro (Alm et al., 2001).
The first ICSI foal produced using oocytes derived from slaughterhouse material was
reported by Squires et al. (1996). Cochran et al. (1998) reported the first successful use of
immature oocytes collected from live mares via OPU for ICSI. The early cleavage stage embryos
were transferred to the uterine tubes of recipient mares resulting in the birth of 2 live foals
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(Cochran et al., 1998). The first equine blastocysts produced entirely in vitro and transferred into
the uteri of recipient mares resulting in a successful pregnancy was reported by Li et al. (2001).
Several other studies report successful production of equine embryos by ICSI, demonstrating
their developmental competence both in vivo (Choi et al., 2004) and in vitro (Hinrichs et al.,
2005). In a study by Choi et al. (2002), the authors established that both fresh and frozen-thawed
spermatozoa may be used for ICSI, with no significant differences in embryo development
observed. Stallion semen subjected to two freeze-thaw cycles is also capable of producing
normal fertilization and blastocyst rates when used for ICSI (Choi et al., 2006). Equine ICSI
embryos cryopreserved on days 7 and 8 of culture are capable of normal embryonic development
after transfer (Lazzari et al., 2020). A considerable effect of season on the likelihood of success
of an OPU-ICSI program and the developmental potential of such embryos has not been
reported. Equine oocytes collected during the nonbreeding season are capable of fertilization by
ICSI and embryo development in vitro (Choi et al., 2016; Mak et al., 2018). Additionally,
Colleoni et al., (2007) described that in vitro embryo production can be performed during the
breeding season as well as the fall and spring transition periods, with no effect on maturation,
cleavage, and blastocyst rates. In other words, OPU-ICSI procedures may proceed year-round,
yielding similar results in both the breeding and nonbreeding seasons.
The success of an ICSI procedure is expressed as the rate of blastocyst development.
Likelihood of success of a commercial OPU-ICSI program can be affected by many factors
including the identity, age, and antral follicle count of the mare (Cuervo-Arango et al., 2019). In
2014, it was reported that in a commercial equine ICSI program, an average of 1.2 blastocysts
were produced per aspiration (Hinrichs et al., 2014). In a later study by Lazzari et al. (2020), an
average of 1.7 to 2 blastocysts per OPU-ICSI session were produced solely from warmblood
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mares. Most recently, Claes and Stout (2022) advertised a mean of 2.12 blastocysts per session in
their clinical IVEP program, with a pregnancy rate > 70% and a subsequent foaling rate of
approximately 60%.
Two major techniques investigated by researchers over the years are conventional ICSI
and Piezo-driven assisted ICSI (cICSI and PDAI, respectively). In cICSI, a sharp microtool is
used to break the sperm tail to immobilize the sperm and disrupt its plasma membrane. The sharp
microtool penetrates both the zona pellucida and the oocyte plasma membrane by mechanical
force and deposits the sperm directly into the cytoplasm (Kimura and Yanagimachi, 1995). In
PDAI, the plasma membrane of the sperm is disrupted by piezoelectric pulses. A blunt microtool
is advanced through the zona and into the cytoplasm driven by several rapid pulses made by the
piezo drill, almost like a microscopic jackhammer (Kimura and Yanagimachi, 1995). It has been
reported that cICSI rates can be quite variable from lab to lab, but it has been described that
cICSI can achieve blastocyst rates comparable to PDAI (Choi et al., 2005; Leisinger et al., 2016).
Moreover, Salgado et al. (2018) did not discover any differences in blastocyst rates of oocytes
subjected to either cICSI or PDAI (39 vs 40%, respectively). In terms of blastocyst quality, it
was reported that nuclear fragmentation rate was higher, and cell number was lower in
blastocysts produced by cICSI (Salgado et al., 2018). Nevertheless, satisfactory fertilization and
blastocyst rates can be achieved with either cICSI or PDAI (Leisinger et al., 2016; Salgado et al.,
2018). Laser-assisted ICSI (LAI) is another modified injection technique that involves the
creation of several tiny holes in the zona with a laser device to aid in the mechanical penetration
of the oocyte by a sharp microtool (Smits et al., 2012). Employment of LAI has not been
reported to significantly improve cleavage or blastocysts rates of injected equine oocytes when
compared to PDAI (Smits et al., 2012).
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2.7.4. In Vitro Culture
Immediately following ICSI, presumptive zygotes are placed into an in vitro culture
environment to facilitate the early stages of embryonic development. Fertilized equine oocytes
are generally cultured in vitro up to the blastocyst stage in a defined medium at 38.2ºC in a
mixed gas atmosphere of 5% CO2, 5% O2, and 90% N2 (Hinrichs et al., 2005). Equine embryos
remain in IVC for 7-10 days post fertilization, after which they may be transferred to a recipient
or cryopreserved for later use (Claes and Stout, 2022). Components of culture media vary, but
often include macromolecules, serum, vitamins, amino acids, antioxidants, antibiotics, and
energy substrates (lactate, pyruvate, or glucose; Morbeck et al., 2014).
In both in vivo and in vitro environments, the fertilized oocyte undergoes multiple
morphological and metabolic changes to eventually arrive at the blastocyst stage. This period of
growth is referred to as preimplantation embryo development. The timing of equine embryo
development in vitro is similar to that observed in vivo, but there are slight differences
(Carnevale and Metcalf, 2019). The presence of two pronuclei (one maternal and one paternal) in
the cytoplasm and two polar bodies in the perivitelline space after ICSI is indicative of
successful in vitro fertilization; however, this cannot be easily visualized in the equine zygote
due to the high amount of dark lipids present (Veeck and Zaninovic, 2003; Carnevale and
Metcalf, 2019). After DNA replication, the zygote progresses through the first mitotic cell
division and is divided into two blastomeres (Veeck and Zaninovic, 2003). A 2-cell equine
embryo is often observed by 24 hours, a 4-cell by 48 hours, and an 8-cell around 72 hours post
fertilization (Bezard et al., 1989). In vivo, compaction is initiated in the equine embryo around
day 4 and results in the establishment of an outer layer of cells that later form the trophectoderm,
and a congregation of inner cells that will become the inner cell mass (ICM; Betteridge et al.,
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1982; Veeck and Zaninovic, 2003). The trophectoderm will later give rise to the placenta, and
the ICM will give rise to the embryo proper (McCue, 2014). Following compaction, the
cavitation process begins, and a blastocoele cavity of fluid forms (Veeck and Zaninovic, 2003).
In the mare, the blastocyst migrates from the uterine tube to the uterus at days 5 or 6 of
development (Betteridge et al., 1982). By day 7, a protective capsule is present in between the
zona pellucida and the layer of trophoblast cells and persists until the blastocyst reaches about 34
mm in diameter (around 21 days of pregnancy; Betteridge et al., 1982). Quality of equine IVP
embryos is often graded on a scale of 1 to 4. Grade 1 embryos are considered excellent
(spherical, cells of uniform size and shape, no fragmentation), grade 2 embryos are considered
fair (moderate abnormalities; irregular shape, cytoplasmic fragmentation), grade 3 embryos are
classified as poor (major abnormalities; high degree of fragmentation, many extruded or
degenerate cells), and grade 4 embryos are degenerate or dead (McKinnon and Squires 1988).
It is important to note that aberrant development of IVP equine embryos has been
observed in culture. In comparison to in vivo derived embryos, in vitro produced equine
blastocysts have lower cell numbers, higher rates of apoptosis, an indistinct separation of the
trophectoderm and ICM cells, as well as a smaller or absent blastocoele cavity (Tremoleda et al.,
2003). Additionally, blastomeres often leak out of the zona through the hole made during ICSI
(Carnevale and Metcalf, 2019).
Various approaches have been taken to achieve acceptable blastocyst rates from in vitro
cultured equine zygotes, including co-culture with somatic cells (Battut et al., 1991; Li et al.,
2001) and in vivo culture of oocytes that underwent ICSI (Galli and Lazzari, 2001; Choi et al.,
2004). Several culture media and culture conditions have been described for the culture of
presumptive equine zygotes. Galli et al. (2002) reported that addition of bovine serum albumin
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(BSA) and amino acids to synthetic oviductal fluid (SOF) culture media resulted in a 14%
blastocyst development rate. In addition, blastocyst rates of 15% were obtained when fertilized
oocytes were cultured in DMEM/F-12 supplemented with 10% fetal bovine serum (Choi et al.,
2004). Culture in DMEM/F-12 medium supplemented with either BSA or FBS under a mixed
gas atmosphere (5% CO2, 5% O2, 90% N2) resulted in blastocyst rates similar to those observed
with in vivo culture of ICSI embryos (~ 27%; Hinrichs et al., 2005; Choi et al., 2006). Utilization
of a modified commercial human embryo culture medium (LifeGlobal®) for the culture of equine
oocytes yielded blastocyst rates of 20% (Hinrichs et al., 2014). The use of a complete human
culture system (SageTM, Origio) by Leisinger et al. (2016) yielded blastocyst rates > 20% using
cICSI. More recently, utilization of a modified SOF-IVC medium supplemented with BSA and
amino acids in a commercial OPU-ICSI program has led to a significant increase in the number
of freezable and transferrable embryos (Lazzari et al., 2020). In summation, media composition
and culture conditions employed by different ICSI laboratories vary widely, and improvements
can always be made to optimize the culture environment for IVC of equine embryos.

2.8. Prolactin and the Oocyte
Prolactin receptors have also been identified in the ovaries of many other species
including mouse, rat, rabbit, bovine, porcine, and human (Poindexter et al., 1979; Waters et al.,
1984; Shirota et al., 1990; Słomczyńska et al., 2001; Kiapekou et al., 2009). Various roles for
prolactin in steroidogenesis, ovulation, and oocyte maturation have been suggested. The effect of
prolactin on oocyte maturation and embryonic development appears to differ with respect to in
vivo and in vitro environments. The addition of human prolactin to granulosa and luteal cell
culture at high concentrations resulted in the suppression of progesterone and estradiol secretion,
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while low concentrations of prolactin increased basal progesterone levels (McNatty et al., 1974;
Lee et al., 1986; Alila et al., 1987). Plus, prolactin levels are higher during the ovulatory period
and luteal phase of the menstrual cycle and transiently increase in women undergoing
gonadotropin treatment for IVF (Vekemans et al., 1977; Oda et al., 1991). Earlier studies claim
that estradiol-induced hyperprolactinemia negatively affected pregnancy outcomes in IVF
patients since treatment with bromocriptine, a dopamine agonist, was reported to improve
fertilization rates of oocytes in hyperprolactinemic patients (Reinthaller et al., 1988). Conversely,
other studies provided evidence that high prolactin was not associated with infertility (Hofmann
et al., 1989; Anthony Pattinson et al., 1990). Laufer et al. (1984) reported that mature fertilized
oocytes associated with a successful pregnancy were retrieved from follicles with higher
prolactin concentrations. In addition, Oda et al. (1991) reported that fertilization and cleavage
rates of oocytes from hyperprolactinemic patients were significantly higher than those with
hypoprolactinemia.
When prolactin antiserum was added to organ culture of porcine antral follicles, it
appeared that meiotic resumption was induced in these oocytes (Baker and Hunter, 1978). This
suggests that prolactin may be involved in the maintenance of meiotic arrest of porcine oocytes.
Using an in vitro perfused rabbit ovary model, Yoshimura et al. (1991) reported that addition of
prolactin (1000 ng/ml) to the perfusion medium greatly inhibited hCG-stimulated ovulations in a
dose-dependent manner. Increased activity of gonadotropin-stimulated plasminogen activator
(PA), which is produced by granulosa cells, is believed to be involved in follicle rupture during
ovulation (Reich et al., 1985). Activity of PA was significantly inhibited in mature follicles upon
exposure to prolactin, which may explain why ovulations were hindered in prolactin-treated
follicles. When evaluating the developmental capacity of these oocytes, a greater percentage of
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blastocysts were produced by oocytes that were matured in the medium with prolactin. Perhaps
the delay in ovulation caused by high prolactin levels is beneficial for meiotic and cytoplasmic
maturation in this species.
Interestingly, homozygous PRLr gene knockout mice proved to be infertile, with multiple
reproductive abnormalities, such as irregular ovulation and deficient preimplantation embryo
development (Ormandy et al., 1997). Kiapekou et al. (2009) elucidated the expression of PRLr in
murine preantral follicles, COCs, and germinal vesicle stage oocytes. In this study, culture of
preantral mouse follicles with or without prolactin was executed to evaluate the effect of
prolactin on early embryonic development in vitro. The maturation rate of oocytes and cleavage
rate of subsequent zygotes post fertilization were significantly higher in the groups cultured with
prolactin than without (64.5 vs 34.5% and 61.9 vs 43%, respectively). In addition, the authors
reported an advanced rate of development to the morulae and blastocyst stages in the prolactin
culture group. Finally, increased blastocyst rates were observed in groups of cumulus-enclosed
bovine oocytes matured in the presence of prolactin (Lebedeva et al., 2008). Together, the
studies reviewed herein suggest that prolactin is involved in the mechanisms associated with the
completion of meiotic and cytoplasmic maturation that is imperative to the acquisition of
developmental competence.

2.9. Rational for Present Experiments
While it has been established that administration of ECP-sulpiride to seasonally
anovulatory mares reliably hastens the date to first ovulation of the year, considerable research is
still needed to investigate the effects of this stimulation protocol on the outcomes of the in vitro
production of embryos. Ovulations from ECP-sulpiride stimulated follicles are fertile in vivo, but
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the in vitro developmental potential of oocytes from these stimulated follicles has yet to be
explored (Oberhaus et al., 2017; Looman, 2020). To the author’s knowledge, this study is the
first to evaluate the meiotic and developmental competence of oocytes collected via OPU from
ECP-sulpiride treated mares through subjection to in vitro maturation, ICSI, and in vitro culture.
The objectives of the experiments described herein were conducted to determine if oocytes from
seasonally anovulatory mares induced to cycle with ECP-sulpiride would have equivalent in
vitro developmental potential to oocytes from naturally occurring follicles of transitional mares
in the spring. We hypothesize that oocytes derived from ECP-sulpiride stimulated follicles will
have similar in vitro developmental competence to oocytes from follicles of naturally
transitioning mares.
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CHAPTER 3. MATERIALS AND METHODS

3.1. Animals
Procedures used in these experiments were approved by the Institutional Animal Care
and Use Committee of the Louisiana State University Agricultural Center. All mares used in
these experiments resided at the LSU Reproductive Biology Center in St. Gabriel, Louisiana and
represented Quarter Horse, Thoroughbred, and light horse-pony cross breeds. Mares were
maintained outdoors with ad libitum access to Bermuda grass pasture and automatic waterers.
Hay prepared from the same pasture was supplemented starting early November. Beginning in
January, mares were limit-grazed on winter Ryegrass. Protein lick tubs were also available ad
libitum (18% All Natural, Positive Feed, Ltd., Sealy, TX).
Beginning in early December 2020 and 2021, all non-pregnant mares were subjected to
ovarian ultrasound once a week and jugular blood samples were collected approximately every
four days to determine progesterone concentrations. Mares were deemed seasonally anovulatory
when no significant ovarian structures were observed (follicles > 20 mm and corpora lutea), and
plasma progesterone concentrations were consistently ≤ 1 ng/mL for at least three weeks prior to
the start of the experiment.
3.2. Experiment One
Treatment
Fourteen light horse and pony-cross anovulatory mares were blocked by breed and age
before random assignment to treatment or control groups. On February 23, 2021, mares assigned
to treatment (n = 7) received 50 mg ECP (Sigma Aldrich, St. Louis, MO) in 1 ml SAIB (Eastman
Chemical Company, Kingsport, TN) while mare assigned to controls (n = 7) received 1 mL
SAIB. One day later, treatment mares received 3 g sulpiride (racemic mixture; Sigma Aldrich) in
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5 mL SAIB while control mares received 5 mL SAIB only. All treatments were administered
intramuscularly. Blood samples were collected via jugular venipuncture into evacuated tubes
containing sodium heparin (Vacuette; Greiner Bio-One, Monroe, NC) one day prior to treatment
with sulpiride and continued daily for 10 days post-treatment to characterize prolactin and LH.
Plasma was frozen at -20 ºC until assays were performed. Ovarian follicular activity was
monitored via ultrasonography (Aloka 550V with 5-Mhz linear-array transducer; Hitachi-Aloka,
Wallingford, CT) daily and continued until May 1. Size and number of ovarian follicles were
recorded.
Ultrasound-Guided Transvaginal Ovum Pick Up
Upon detection of the first 30 mm follicle, the mare was subjected to ultrasound-guided
transvaginal OPU. For the procedure, mares were restrained in palpation stocks and sedated with
detomidine (0.005-0.01 mg/kg body weight (BW); Dormosedan, Zoetis, Parsippany, NJ) and
butorphanol (0.005-0.01 mg/kg BW; Torbugesic, Zoetis, Parsippany, NJ), administered
intravenously, to minimize movement during the procedure. Mares also received 0.3 mg/kg BW
of N-butylscopolammonium bromide (Buscopan, Boehringer Ingelheim, Duluth, GA),
intravenously, to decrease rectal tone. After aseptic preparation of the perineal area, a
transvaginal probe (Hitachi-Aloka, Wallingford, CT) was inserted into the vagina. The ovary
was then manipulated and fixed by rectal palpation against the vaginal wall. A 60 cm, 12-gauge
double lumen needle (MILA international, Inc, Florence, KY), connected to a collection bottle,
was advanced through the vaginal wall to aspirate follicles using a vacuum pump (Cook
Medical, Bloomington, IN). All follicles ≥ 8 mm were targeted for OPU, and aspirates from each
session were collected and pooled into a separate set of collection bottles based on treatment
group and follicle diameter (8-19 mm, 20-29 mm, ≥ 30 mm). Follicles were flushed four to eight
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times with commercial embryo flush media (ViGRO Complete Flush Solution, Vetoquinol, Fort
Worth, TX) supplemented with 5 USP units/mL heparin sodium (Sagent Pharmaceuticals,
Schaumburg, IL). Following the procedure, mares received flunixin meglumine (0.5 mg/kg BW;
Banamine; Merck Animal Health, Madison, NJ) and procaine penicillin (20,000 units/kg BW;
Agri-Cillin; AgriLabs, St. Joseph, MO).
Oocyte Recovery and Maturation
Throughout the following steps of the experiment, oocytes were grouped separately based
on follicle diameter. Aspirates were filtered through a filter containing a 75-micron stainless steel
screen (EmCon; Agtech, Manhattan, KS) to isolate oocytes. Oocytes were identified using a
stereomicroscope (SMZ1500, Nikon Instruments Inc, Melville, NY) and collected into 2 mL
cryovials (reference). Oocytes were held 14 to 20 hours (overnight) at room temperature
(approximately 22ºC) in holding media (Leisinger et al., 2016; EQ-Hold; ivf Biosciences,
Cornwall, UK) before being placed in maturation media (EQ-IVM; ivf Biosciences) and
incubated at 38.2ºC at 6% CO2 for 30 hours.
In vitro matured oocytes were fixed and mounted onto microscope slides to visualize the
MII plate. Mounting of oocyte was achieved by placing oocyte onto a microscope slide within a
drop of maturation media, depositing 4 small spots of paraffin wax and petroleum jelly mixture
onto the edges of a cover slip, placing the cover slip over the oocyte on the microscope slide, and
tapping gently with a utensil until a bubble formed around the oocyte, indicating that the oocyte
is adequately pressed onto the slide. Microscope slides were placed in 45% acetic acid in 95%
ethanol mixture in a Coplin jar for 3 days to remove lipids from the cytoplasm of the oocyte(s).
Slides were then dried by blotting and a single drop of orcein stain (10 mg/mL water and acetic
acid, 60:40 vol:vol) was placed on one open side of the coverslip. A disposable wipe was placed
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on the side of the coverslip opposite from the stain to draw the stain across the slide. Stained
oocytes were viewed using brightfield microscopy under 400X magnification to visualize a MII
plate.
Radioimmunoassay
Frozen plasma samples were thawed, and concentrations of prolactin and LH determined
by radioimmunoassays previously developed and validated in our laboratory (Cartmill et al.,
2003; Colborn et al., 1991; Thompson, Godke, et al., 1983; Thompson, Reville, et al., 1983).
Intra- and inter-assay coefficient of variation and levels of detection were 7%, 12%, and 0.2
ng/mL for prolactin and 6%, 9%, and 0.2 ng/mL for LH.
3.3. Experiment Two
Animals
Mares for this experiment were housed at one of two Louisiana Agricultural Experiment
Station farms: the Central Research Station Horse Unit on the Ben Hur Plantation and the
Reproductive Biology Center. The two farms were located approximately 9 miles apart south of
the Louisiana State University main campus in Baton Rouge. Nutritional management and
determination of seasonal anovulation was identical to experiment one.
ECP-Sulpiride Treatment
Twenty-two light horse and pony-cross anovulatory mares were identified as seasonally
anovulatory and blocked by breed and age before random assignment to treatment or control.
Dose and source of ECP and sulpiride and treatment schedule were identical to experiment one.
On February 12, 2022, mares assigned to treatment (n = 11) received 50 mg ECP followed by 3 g
sulpiride, both suspended in SAIB, one day later while controls (n = 11) received SAIB only.
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Intracytoplasmic Sperm Injection and In Vitro Culture
An equine ICSI media suite (ivf Biosciences) was used for the following procedures.
Oocyte holding and maturation procedures were identical to those utilized in experiment 1.
Throughout the experiment, oocytes were matured, subjected to ICSI, and cultured separately
based on follicle diameter. Semen from the same ejaculate was used for all ICSI procedures.
Frozen semen extended with ButoCrio (Butopharma USA, Pheonix, AZ) from a single stallion of
proven ICSI fertility was prepared in EQ-SemenPrep media. Cumulus-expanded oocytes were
stripped of cumulus cells in 100 µL EQ-Strip, then transferred to EQ-ICSI and evaluated for
extrusion of the first polar body. Oocytes with polar bodies were transferred to 10 µL drops of
EQ-ICSI in preparation of sperm injection. A single sperm was selected, and the microinjection
pipette was used to break the tail to immobilize the sperm. The sperm was then aspirated tail first
into the microinjection pipette and injected into the oocyte at the 3 o’clock position while the
oocyte was held in place by a holding pipette. The sperm was then delivered into the oocyte
cytoplasm. Presumptive zygotes were then transferred to 500 µL EQ-IVC1 with a 400 µL oil
overlay and incubated at 38.2ºC at 6% O2, 6% CO2, and 88% N2 for 3 days. On day 3 of culture,
presumptive zygotes were evaluated for cleavage.
Statistical Analyses
Data were analyzed by GraphPad Prism 9.3.1 (350) (GraphPad Software, Inc, San Diego,
CA). All variables were analyzed for normal distribution using Shapiro-Wilk Test. Single-point
data (days to ovarian response and number of follicles) were analyzed by two-tailed Student’s ttest. Recovery, maturation, and cleavage rates were first analyzed based on follicle diameter
using a Fisher’s exact test. When no statistical differences were detected, recovery and
maturation rates of oocytes from experiments 1 and 2 were pooled and analyzed by Fisher’s
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exact test. Cleavage rates from experiment 2 were also compared using Fisher’s exact test.
Concentrations of prolactin and LH were analyzed by mixed-model ANOVA with repeated
sampling. For all tests, significance was set a P ≤ 0.05. For data sets in which the variance tended
to be proportional to the mean (multiplicative effects), parallel ANOVA were performed both on
the raw data and on log-transformed data. When log transformation had little effect on the
overall analyses or our interpretation of the results, we chose to present non-transformed data in
the figures. When appropriate, means were separated by Fisher’s Least Significant Difference
test.
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CHAPTER 4. RESULTS

4.1. Ovarian Responses
An ovarian response was defined as the presence of a follicle at least 30 mm in diameter
within 25 days after treatment with sulpiride. Mean day to first 30 mm follicle after treatment
with ECP and sulpiride in experiment 1 and 2 are presented in Figure 1. All seven ECPsulpiride-treated mares in experiment 1 responded within 14 days of treatment with a mean day
of 11.6 ± 1 d (Figure 1). Mean day of calendar year to first 30 mm follicle was advanced (P <
0.01) by 23 days in mares treated with ECP-sulpiride compared to mares that received vehicle
only (March 5 ± 2.7 d vs March 27 ± 17 d). Of the 11 mares in experiment 2 treated with ECPsulpiride, 10 mares responded within 15 days of treatment with a mean day of 12.4 ± 2.6 d
(Figure 1). Mean calendar day of year to first 30 mm follicle was advanced (P < 0.001) by 19
days in mares treated with ECP-sulpiride compared to mares administered vehicle only
(February 25 ± 8.5 d vs March 15 ± 12 d).

Figure 1. Mean day to first 30 mm follicle after treatment with 50 mg ECP and 3 g sulpiride or
vehicle only in experiments 1 and 2. Means differ at P < 0.05 (*) or < 0.001 (***).
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There were similar numbers of ovarian follicles present upon detection of the first 30 mm
follicle in Exp 1; however, a greater (P < 0.001) number of follicles were observed on the ovaries
of control mares than on mares treated with ECP-sulpiride in Exp 2 (Figure 2).

Figure 2. Mean number of ovarian follicles present upon detection of the first 30 mm follicle in
experiment 2 in both mares treated with 50 mg ECP and 3 g sulpiride (n = 11) and mares treated
with vehicle only (n = 11). Means differed at P < 0.001 (***).

4.2. Endocrine Responses of Responding and Nonresponding Mares
Mean prolactin concentrations of mares treated with ECP-sulpiride or vehicle only in
experiments are presented in Figure 3. Prolactin was stimulated (P < 0.0001; Figure 3A) in mares
treated with ECP-sulpiride for at least 7 days after sulpiride treatment. There was an interaction
(P < 0.0001) between treatment and day for mean plasma prolactin with concentrations being
higher on days 0.5 through 7. Plasma prolactin concentrations of mares treated with ECPsulpiride or vehicle only in Experiment 2 are presented as geometric means in Figure 3B.
Prolactin was stimulated (P < 0.0001) in mares treated with ECP-sulpiride for at least 10 days
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after sulpiride treatment. There was an interaction (P < 0.0001) between treatment and day for
mean plasma prolactin with concentrations being higher on days 1 through 10.

Figure 3. Mean plasma prolactin concentrations of seasonally anovulatory mares treated with 50
mg ECP and 3 g sulpiride or vehicle only in Experiment 1 (panel A) and Experiment 2 (panel B;
geometric means). Asterisks indicate differences at P < 0.001. Pooled SEM was 5.75 ng/mL for
panel A and 0.67 ng/mL for panel B.

Mean plasma LH concentrations of mares treated with ECP-sulpiride or vehicle in both
experiments are presented in Figure 4. In experiment 1, LH was stimulated (P = 0.03; Figure 4A)
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in mares treated with ECP-sulpiride when compared to mares that received vehicle only. There
was an interaction (P < 0.0001) between treatment and day for plasma LH with concentrations
greatest in ECP-sulpiride treated mares at days 9 and 10 post treatment. Mean plasma LH
concentrations of mares treated with ECP-sulpiride vs mares treated with vehicle only in
Experiment 2 are presented in Figure 4B. The LH response to treatment did not differ (P = 0.06)
between groups; however, there was an interaction (P < 0.0001) between treatment and day with
plasma LH concentrations greatest in ECP-sulpiride treated mares at days 9 and 10 post
treatment.

Figure 4. Mean plasma LH concentrations of seasonally anovulatory mares treated with 50 mg
ECP and 3 g sulpiride or vehicle only in Experiment 1 (panel A) and Experiment 2 (panel B).
Asterisks indicate differences at P < 0.0001. Pooled SEM was 0.44 ng/mL for panel A and 0.62
ng/mL for panel B.
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4.3. Recovery, Maturation, and Cleavage Rates
Recovery and maturation rates of oocytes derived from seasonally anovulatory mares
treated with ECP-sulpiride or vehicle only were pooled between both experiments. Overall rates
from both experiments are presented in Table 1. Rates from experiments 1 and 2 are presented
separately in Tables 2 and 3, respectively. Oocytes were pooled within treatments based on
follicle diameter (8-19 mm, 20-29 mm, and ≥ 30 mm). Recovery rates were calculated based on
the number of oocytes obtained from the number of follicles successfully aspirated and flushed.
Pooled recovery rates of oocytes derived from ECP-sulpiride treated mares and mares
administered vehicle only were 41.6% (27/65) and 45.1% (55/122), respectively, and did not
differ (Figure 5).

Table 1. Overall recovery, maturation, and cleavage rates of oocytes derived
from seasonally anovulatory mares treated with ECP and sulpiride.
Percentage
Recovery

ECP-Sulpiride
41.6%
(27/65)

Control
45.1%
(55/122)

P-value
0.77

Maturation

55.6%
(15/27)

65.4%
(36/55)

0.47

71.4%
(5/7)
Abbrev: ECP = estradiol cypionate
*Experiment 2 only

63.1%
(19/31)

0.99

Cleavage*
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Table 2. Recovery and maturation rates of oocytes derived from seasonally
anovulatory mares treated with ECP and sulpiride in experiment 1.
Percentage

ECP-Sulpiride

Control

P-value

Recovery

46.4%
(13/28)

33.3%
(7/21)

0.39

Maturation

61.5%
(8/13)

71.4%
(5/7)

0.99

Abbrev: ECP = estradiol cypionate

Table 3. Recovery, maturation, and cleavage rates of oocytes derived from
seasonally anovulatory mares treated with ECP and sulpiride in experiment 2.
Percentage
Recovery

ECP-Sulpiride
40.5%
(15/37)

Control
52.4%
(53/101)

P-value
0.25

Maturation

46.6%
(7/15)

58.4%
(31/53)

0.55

Cleavage

71.4%
(5/7)

63.1%
(19/31)

0.99

Abbrev: ECP = estradiol cypionate

Pooled maturation rates of oocytes derived from seasonally anovulatory mares treated
with ECP-sulpiride and mares that received vehicle only based on follicle diameter are presented
in Figure 6. In experiment 1, maturation rates were calculated based on the number of oocytes
that contained a metaphase II plate at the time of staining from the number of follicles recovered.
In experiment 2, maturation rates were calculated based on the number of oocytes that contained
an extruded first polar body in the perivitelline space at the time of ICSI from the number of
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follicles recovered. Maturation rates of oocytes derived from ECP-sulpiride treated mares did not
differ from mares that were administered vehicle only (55.6 vs 65.4%, respectively).

Figure 5. Pooled recovery rates of oocytes derived from seasonally anovulatory mares treated
with 50 mg ECP and 3 g sulpiride or vehicle only. No differences were detected.

Cleavage rates of embryos derived from oocytes from ECP-sulpiride treated mares vs
mares that received vehicle only based on follicle diameter in Experiment 2 are presented in
Figure 7. Cleavage rates were calculated based on the number of embryos that cleaved from the
number of oocytes that underwent ICSI. Cleavage rates of embryos derived from ECP-sulpiride
treated mares vs mares administered vehicle only were 71.4% (5/7) and 61.3% (19/31),
respectively. Based on follicle diameter, cleavage rates of embryos from ECP-sulpiride treated
mares and mares that received vehicle only did not differ.

42

Figure 6. Pooled maturation rates of oocytes derived from seasonally anovulatory mares treated
with 50 mg ECP and 3 g sulpiride or vehicle only. No differences were detected.

Figure 7. Cleavage rates of oocytes derived from seasonally anovulatory mares treated with 50
mg ECP and 3 g sulpiride or vehicle only. No differences were detected.
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CHAPTER 5. DISCUSSION
The use of dopamine antagonists to induce early cyclicity in seasonally anovulatory
mares has been the subject of much research; however, to date, this is the first study to evaluate
the in vitro developmental potential of oocytes derived from seasonally anovulatory mares
treated with a dopamine antagonist, namely sulpiride. In experiments 1 and 2, a treatment
success rate, defined as a 30 mm follicle within 25 days of treatment with sulpiride, of 100% and
90%, respectively, was observed in mares administered 50 mg ECP followed by 3 g sulpiride.
All responding mares produced an ovulatory sized follicle in an average of 11 days after
sulpiride treatment. Other studies utilizing estradiol and sulpiride to hasten the date to first
ovulation reported success rates ranging from 39-89%, depending on the vehicle and number of
injections used (Kelley et al., 2006; Mitcham, 2012; Oberhaus et al., 2017, 2018; Looman,
2020). In the present study, mean day to first 30 mm follicle of the year was advanced in
anovulatory mares administered ECP-sulpiride by an average of 21 days, which is comparable to
previous reports (Oberhaus et al., 2018; Looman, 2020). The overall success rate of 94%
observed in the present study utilizing only one ECP injection one day prior to a single sulpiride
injection is the most successful response to treatment thus far.
One observation made in experiment 2 was that naturally transitioning mares (controls)
appeared to have more follicles available for aspiration in comparison to mares treated with
ECP-sulpiride; however, this was not an unexpected result. The ovaries of an anestrous mare are
small and inactive in terms of follicle development. In comparison, the ovaries of a naturally
transitioning mare have an increased number of follicles present, often resembling a cluster of
grapes (M. Vetter, personal observation). This statement agrees with that of Donadeu and
Pedersen (2008), who observed that follicular waves of the spring transition produced more
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follicles than waves of both the anovulatory and ovulatory seasons. The dominant, stimulated
follicle of most treated mares occupied a majority of the ovary, ultimately reducing the number
of subordinate follicles available for aspiration. Contrarily, the ovaries of control mares often
contained multiple subordinate follicles in addition to the ovulatory sized follicle. The marked
difference in ovarian characteristics (i.e., number of follicles) of ECP-sulpiride treated and
naturally transitioning mares at the time of OPU suggests that seasonally anovulatory mares
would serve as the superior control group, therefore providing a more precise comparison of
ovarian activity and oocyte competence with and without treatment.
It is important to note is that while 90% of all mares in both groups eventually produced a
follicle ≥ 30 mm, the large follicle(s) present on the ovaries of control mares were unlikely to
ovulate due to the low levels of circulating gonadotropins and steroidogenic incompetence of
follicles that are typically present during the spring transition. In contrast, anestrous mares
administered ECP-sulpiride in previous studies are capable of achieving an advanced first
ovulation of the year well before a naturally transitioning mare (Oberhaus et al., 2017; Looman,
2020). In experiment 1, follicular activity of ECP-sulpiride treated mares subjected to OPU was
monitored in the weeks following the procedure, and most mares resumed regular cyclicity and
achieved normal, second ovulations. It appears that treatment with ECP-sulpiride induces
seasonally anovulatory mares into an advanced transition-like state, or in some cases, entirely
bypasses the erratic ovarian activity often associated with the spring transition.
It is understood that the competence of equine oocytes is positively correlated with
follicle size (Goudet et al., 1997; Hinrichs and Schmidt, 2000). Recovery, maturation, and
cleavage rates were analyzed based on follicle diameter to determine if ECP-sulpiride treatment
had an effect on oocyte competence according to these parameters; however, no statistical
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differences were detected. Though, upon observation, it appeared that a greater number of
oocytes were collected from follicles 8-19 mm in diameter, but their ability to mature and cleave
following ICSI seemed inferior to oocytes collected from larger follicles (20-29 mm and ≥ 30
mm). This effect has been described previously, where recovery rates from follicles < 20 mm
were greater, but these oocytes lacked meiotic competence when compared to those originating
from follicles > 20 mm (Hinrichs and Schmidt, 2000).
A correlation between stimulated prolactin concentrations and ovarian response has not
been observed, neither has a threshold concentration of prolactin been determined. In essence, a
prolactin response does not guarantee an ovarian response. All sulpiride-treated mares had
elevated prolactin concentrations after treatment. Mares responding to treatment displayed
prolactin concentrations ≤ 60 ng/mL. There is a possibility that threshold prolactin
concentrations must be reached in order for a mare to respond, but the exact value correlated
with response has yet to be identified and could vary between individual mares (Oberhaus et al.,
2017). Most unstimulated cycling mares have prolactin concentrations around 10-15 ng/mL in
the summer (Thompson and Oberhaus, 2015). Therefore, it is likely that induction of cyclicity in
anovulatory mares with ECP-sulpiride requires stimulation of prolactin to at least those
concentrations, which were achieved in the present experiments.
Pretreatment with ECP produced elevated LH concentrations starting approximately 5
days after treatment with ECP which is consistent to the timing reported in other studies
(Oberhaus et al., 2017; Looman, 2022; Oberhaus et al., 2022). Similar to prolactin, a threshold
concentration of LH after stimulation with ECP has not been determined, although failure of
either endocrine response typically results in no ovarian response.
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The mechanism by which prolactin induces such rapid follicular growth in mares treated
with ECP-sulpiride has yet to be elucidated. It can be postulated that stimulation of angiogenic
factors such as vascular endothelial growth factor (VEGF) could promote rapid folliculogenesis
as VEGF induces vascular growth in follicles and increases permeability of endothelial cells
(Reynolds and Redmer, 1998). Prolactin present in follicular fluid or added to culture has been
found to promote endothelial cell proliferation by inducing expression of VEGF, which is
expressed in many cell types, including theca, granulosa, luteal, and cumulus cells of many
species (Yamamoto et al., 1997; Barboni et al., 2000; Watson and Al-zi’abi, 2002; Al-zi’abi et
al., 2003; Goldhar et al., 2005; Castilla et al., 2009). Highly vascularized preovulatory follicles
are more competent than transitional follicles with less vascularity; enhanced blood flow allows
for transport of oxygen, nutrients, substrates, and circulating gonadotropins to aid in follicular
growth and steroidogenesis (Watson and Al-zi’abi, 2002). The promotion of angiogenesis by
prolactin and the establishment of rich blood flow to the growing follicles could be contributing
to the rapid follicular growth and maturation repeatedly observed in ECP-sulpiride treated mares.
The late-stage follicular growth induced by ECP-sulpiride treatment may be attributed to
an upregulation in LH receptors. Failure of follicles to ovulate during early spring can be
attributed to inadequate follicular fluid and circulating estradiol concentrations (Davis and Sharp,
1991; Watson et al., 2004). Larger follicles during the breeding season have higher LH receptor
mRNA content and follicular steroidogenic activity when compared to large follicles that emerge
during the spring transition (Watson et al., 2004). Increase in follicular steroidogenic activity
approaching the breeding season results in an elevation of estradiol in circulation, which has
been suggested to be a key factor in stimulating the release of LH prior to the first ovulation of
the year (Sharp et al., 2001). It has been established that stimulated follicles from these
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responding mares have LH receptor content and steroid production equivalent to naturally
occurring follicles in the spring (Oberhaus et al., 2018). Such follicles have the ability to respond
to LH input in the same way an unstimulated ovulatory-sized follicle would. We propose that
treatment with ECP-sulpiride prompts an increase in estradiol and a subsequent upregulation in
LH receptor expression, endowing the follicle with gonadotropic and steroidogenic competence
sufficient to achieve late-stage follicular growth and ovulation.
In bovine, a single OPU session usually results in recovery rates ≥ 70% (Galli et al.,
2014). In contrast, an overall recovery rate of 41.6% observed in treated mares of the present
study could be considered acceptable in the equine. The recovery rates observed in the present
study resemble those of Mak et al. (2018), who reported an oocyte recovery rate of 51% in the
nonbreeding season and 39% in the breeding season. In a large scale clinical OPU-ICSI program,
a total of 515 OPU sessions yielded an average recovery rate of 53%, which is not far off from
the 41.6% recovery rate achieved in the present study, despite a lesser total of OPU sessions
performed (Claes and Stout, 2022). Other studies report rates closer to 60% (Galli et al., 2007;
Choi et al., 2016). Aspirations performed on treated mares in different aspiration sessions
produced recovery rates ranging from 20-66%. This variability could be due to several factors:
the mare’s identity (age, breed), her behavior during the procedure, the number and size of
follicles present on the ovaries at the time of OPU, or whether all punctured follicles were
adequately flushed and scraped during aspiration.
Maturation rates of oocytes derived from ECP-sulpiride stimulated follicles did not differ
from those derived from naturally occurring follicles in the spring. It has been previously
observed that maturation rate of oocytes collected during both the breeding and nonbreeding
seasons do not differ (Mak et al., 2018). Maturation rates of both treatment groups observed in
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the present study are lower than the near 80% maturation rates reported by Mak et al. (2018) and
the > 80% maturation rate reported by Leisinger et al. (2016). In contrast, the rate of oocyte
maturation achieved in the current experiments is comparable to earlier studies that report rates
of approximately 60% (Colleoni et al., 2007; Jacobson et al., 2010; Choi et al., 2016; Claes and
Stout, 2022). No detrimental effects on maturation were observed in oocytes derived from
stimulated mares in the present study. Perhaps the favorable in vitro maturation conditions (e.g.,
culture medium) facilitated sufficient nuclear maturation and contributed equally to the
acquisition of meiotic competence of oocytes from both stimulated and unstimulated mares. In
essence, oocytes from induced follicles of seasonally anovulatory mares appeared to mature
equally to those from naturally occurring follicles.
Cleavage rate of oocytes collected from anovulatory follicles stimulated with ECPsulpiride did not differ from those collected from unstimulated transitional follicles. The 70%
cleavage rate of treatment oocytes observed in this study resemble those of a clinical or
commercial equine IVP program using immature oocytes collected via OPU for ICSI (Colleoni
et al., 2007; Galli et al., 2013; Leisinger et al., 2016; Cuervo-Arango et al., 2019). Conventional
ICSI is simple and repeatable, and utilization of this technique in the present study resulted in a
reasonable cleavage rate. Induction of folliculogenesis through stimulation of prolactin and LH
appeared to facilitate growth of treatment oocytes similarly to what would take place during a
normal cycle. Acceleration of follicle growth induced by treatment did not appear to negatively
affect the acquisition of meiotic and cytoplasmic competence of oocytes from ECP-sulpiride
stimulated follicles. Based on the results of the present study, oocytes recovered from stimulated
follicles acquired the ability to reach maturity and undergo cleavage similarly to oocytes from
naturally transitioning mares.
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A limitation of the current study was the small number of oocyte observations for
statistical analysis, but that was to be expected given the average number of oocytes collected
from a single mare by OPU. Despite this, the current study was very practical and most
resembled the real-world, unpredictable results often received in an equine IVP program. The
ultimate determination of developmental competence is the ability of the oocyte to mature to
MII, undergo cleavage, form a blastocyst, and develop to term, producing a healthy offspring
(Sirard et al., 2006). Based on the observations made in the present study, oocytes derived from
ECP-sulpiride stimulated follicles are able to reach MII in culture and cleave following ICSI.
Using blastocyst development as an endpoint in future studies to evaluate the competence of
ECP-sulpiride oocytes would aid in further characterization of their developmental potential. In
addition, transcriptomic analysis of follicular cells and oocytes from ECP-sulpiride treated mares
is currently underway in order to further understand how ECP-sulpiride treatment affects the
follicular environment and subsequent oocyte developmental competence at the transcript level.
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SUMMARY AND CONCLUSIONS
In conclusion, follicle development and consequent oocyte growth can be induced by
treating seasonally anovulatory mares with ECP-sulpiride. Utilization of this treatment allows
anovulatory mares to cycle earlier in the year, providing additional opportunities to produce
offspring from valuable horses, both in vivo and in vitro. The disinhibition of prolactin through
the antagonistic effects of sulpiride on dopamine and the stimulation of LH by ECP are
requirements for an anovulatory mare to achieve early cyclicity. Generation of elevated prolactin
and LH concentrations by ECP-sulpiride facilitates growth of follicles comparable to those
observed in the natural breeding season. The growth of oocytes and accumulation of molecules
needed to support fertilization and cleavage is not compromised by the rapid follicular growth
induced by treatment. In addition, recovery of immature oocytes via OPU following induction of
cyclicity with ECP-sulpiride is not affected by treatment. Overall, treatment with ECP-sulpiride
is an efficient method to stimulate ovarian activity in anovulatory mares without compromising
the quality of oocytes within stimulated follicles. Utilization of this protocol could potentially
provide more opportunities for positive outcomes in ART such as the in vitro production of
embryos through OPU and ICSI.
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